Sponsor of the Day:
Jerkmate
https://c19early.org/bmeta.html
Bromhexine for COVID-19: real-time meta-analysis of 7 studies
7 bromhexine COVID-19 controlled studies. 43% improvement, p = 0.072.
covid 19 realtime meta analysis7studies
https://c19early.org/rg
Regdanvimab for COVID-19: real-time analysis of 17 studies
Regdanvimab for COVID-19: real-time analysis of 17 studies
covid 19 realtime analysis17 studies
https://c19early.org/lfr
Lufotrelvir for COVID-19: real-time analysis of 4 studies
Lufotrelvir for COVID-19: real-time analysis of 4 studies
covid 19 realtime analysis4 studies
https://c19early.org/u
Budesonide for COVID-19: real-time analysis of 41 studies
Budesonide for COVID-19: real-time analysis of 41 studies
covid 19 realtime analysisbudesonide41studies
https://c19early.org/xnx
Xiannuoxin for COVID-19: real-time analysis of 9 studies
Xiannuoxin for COVID-19: real-time analysis of 9 studies
covid 19 realtime analysisstudies
https://c19early.org/mtz
Metronidazole for COVID-19: real-time analysis
Metronidazole for COVID-19: real-time analysis
covid 19 realtime analysismetronidazole
https://c19early.org/k
Probiotics for COVID-19: real-time analysis of 66 studies
Probiotics for COVID-19: real-time analysis of 66 studies
covid 19 realtime analysisprobiotics66studies
https://c19early.org/no
Nitric Oxide for COVID-19: real-time analysis of 29 studies
Nitric Oxide for COVID-19: real-time analysis of 29 studies
covid 19 realnitric oxidetime analysis29studies
https://c19early.org/b9meta.html
Vitamin B9 for COVID-19: real-time meta-analysis of 18 studies (12 treatment studies and 6...
12 vitamin B9 COVID-19 controlled studies. 8% increased risk, p = 0.6.
covid 19 realtime meta analysisvitamin b918studies
https://c19early.org/b9
Vitamin B9 for COVID-19: real-time analysis of 46 studies
Vitamin B9 for COVID-19: real-time analysis of 46 studies
covid 19 realvitamin b9time analysis46studies
https://c19early.org/bt
Bebtelovimab for COVID-19: real-time analysis of 16 studies
Bebtelovimab for COVID-19: real-time analysis of 16 studies
covid 19 realtime analysis16studies
https://c19early.org/chx
Chlorhexidine for COVID-19: real-time analysis of 25 studies
Chlorhexidine for COVID-19: real-time analysis of 25 studies
covid 19 realtime analysis25 studieschlorhexidine
https://c19early.org/gbp
Gabapentin for COVID-19: real-time analysis of 2 studies
Gabapentin for COVID-19: real-time analysis of 2 studies
covid 19 realtime analysis2 studiesgabapentin
https://c19early.org/pp
Propolis for COVID-19: real-time analysis of 21 studies
Propolis for COVID-19: real-time analysis of 21 studies
covid 19 realtime analysis21 studiespropolis
https://c19early.org/zan
Zansecimab for COVID-19: real-time analysis
Zansecimab for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/ixe
Ixekizumab for COVID-19: real-time analysis
Ixekizumab for COVID-19: real-time analysis
covid 19 realtime analysisixekizumab
https://c19early.org/hp
Hydrogen Peroxide for COVID-19: real-time analysis of 27 studies
Hydrogen Peroxide for COVID-19: real-time analysis of 27 studies
covid 19 realhydrogen peroxidetime analysis27studies
https://c19early.org/cpc
Cetylpyridinium Chloride for COVID-19: real-time analysis of 24 studies
Cetylpyridinium Chloride for COVID-19: real-time analysis of 24 studies
covid 19 realtime analysischloride24studies
https://c19early.org/cpm
Chlorpheniramine for COVID-19: real-time analysis of 6 studies
Chlorpheniramine for COVID-19: real-time analysis of 6 studies
covid 19 realtime analysis6 studieschlorpheniramine
https://c19early.org/ameta.html
Favipiravir for COVID-19: real-time meta-analysis of 74 studies
74 favipiravir COVID-19 controlled studies. 11% improvement, p = 0.0096.
covid 19 realtime meta analysisfavipiravir74studies
https://c19early.org/ibz
Ibuzatrelvir for COVID-19: real-time analysis
Ibuzatrelvir for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/q
Quercetin for COVID-19: real-time analysis of 120 studies
Quercetin for COVID-19: real-time analysis of 120 studies
covid 19 realtime analysisquercetin120studies
https://c19early.org/lrmeta.html
Leritrelvir for COVID-19: real-time meta-analysis of 2 studies
2 leritrelvir COVID-19 controlled studies. 21% improvement, p = 0.022.
covid 19 realtime meta analysis2 studies
https://c19early.org/dnase
Dornase alfa for COVID-19: real-time analysis of 8 studies
Dornase alfa for COVID-19: real-time analysis of 8 studies
covid 19 realtime analysis8 studiesalfa
https://c19early.org/s
Remdesivir for COVID-19: real-time analysis of 154 studies
Remdesivir for COVID-19: real-time analysis of 154 studies
covid 19 realtime analysisremdesivir154studies
https://c19early.org/e4
Estetrol for COVID-19: real-time analysis
Estetrol for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/spv
Sipavibart for COVID-19: real-time analysis of 5 studies
Sipavibart for COVID-19: real-time analysis of 5 studies
covid 19 realtime analysis5 studies
https://c19early.org/rav
Ravulizumab for COVID-19: real-time analysis of 2 studies
Ravulizumab for COVID-19: real-time analysis of 2 studies
covid 19 realtime analysis2 studies
https://c19early.org/hh
HH-120 for COVID-19: real-time analysis of 2 studies
HH-120 for COVID-19: real-time analysis of 2 studies
covid 19 realhh 120time analysisstudies
https://c19early.org/r
Casirivimab/imdevimab for COVID-19: real-time analysis of 62 studies
Casirivimab/imdevimab for COVID-19: real-time analysis of 62 studies
covid 19 realtime analysiscasirivimab62studies
https://c19early.org/bms
BMS mAbs for COVID-19: real-time analysis
BMS mAbs for COVID-19: real-time analysis
covid 19 realtime analysisbmsmabs
https://c19early.org/sa58
SA58 for COVID-19: real-time analysis of 3 studies
SA58 for COVID-19: real-time analysis of 3 studies
covid 19 realtime analysis3 studiessa58
https://c19early.org/vameta.html
Vitamin A for COVID-19: real-time meta-analysis of 21 studies (14 treatment studies and 7...
14 vitamin A COVID-19 controlled studies. 33% improvement, p = 0.004.
covid 19 realtime meta analysis21 studiesvitamin14
https://c19early.org/paw
Plasma-activated water for COVID-19: real-time analysis
Plasma-activated water for COVID-19: real-time analysis
covid 19 realtime analysisplasmaactivatedwater
https://c19early.org/dt
Diet for COVID-19: real-time analysis of 62 studies
Diet for COVID-19: real-time analysis of 62 studies
covid 19 realtime analysisdiet62studies
https://c19early.org/efm
Efmarodocokin alfa for COVID-19: real-time analysis
Efmarodocokin alfa for COVID-19: real-time analysis
covid 19 realtime analysisalfa
https://c19early.org/o
Colchicine for COVID-19: real-time analysis of 71 studies
Colchicine for COVID-19: real-time analysis of 71 studies
covid 19 realtime analysiscolchicine71studies
https://c19early.org/atl
Atilotrelvir for COVID-19: real-time analysis
Atilotrelvir for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/admeta.html
Adintrevimab for COVID-19: real-time meta-analysis of 2 studies
2 adintrevimab COVID-19 controlled studies. 43% improvement, p = 0.48.
covid 19 realtime meta analysis2 studies
https://c19early.org/x
Proxalutamide for COVID-19: real-time analysis of 12 studies
Proxalutamide for COVID-19: real-time analysis of 12 studies
covid 19 realtime analysis12 studies
https://c19early.org/pgsn
rhu-pGSN for COVID-19: real-time analysis
rhu-pGSN for COVID-19: real-time analysis
covid 19 realtime analysisrhu
https://c19early.org/egcg
Epigallocatechin Gallate for COVID-19: real-time analysis of 6 studies
Epigallocatechin Gallate for COVID-19: real-time analysis of 6 studies
covid 19 realtime analysis6 studiesepigallocatechingallate
https://c19early.org/hhmeta.html
HH-120 for COVID-19: real-time meta-analysis of 2 studies
2 HH-120 COVID-19 controlled studies. 49% improvement, p = 0.25.
covid 19 realtime meta analysishh 120studies
https://c19early.org/evmeta.html
Ensovibep for COVID-19: real-time meta-analysis of 2 studies
2 ensovibep COVID-19 controlled studies. 47% improvement, p = 0.37.
covid 19 realtime meta analysis2 studies
https://c19early.org/vf
Vidofludimus Calcium for COVID-19: real-time analysis
Vidofludimus Calcium for COVID-19: real-time analysis
covid 19 realtime analysiscalcium
https://c19early.org/gmeta.html
Iota-carrageenan for COVID-19: real-time meta-analysis of 1 study
1 iota-carrageenan COVID-19 controlled study. 80% improvement, p = 0.018.
covid 19 realtime meta analysisiotacarrageenanstudy
https://c19early.org/efzo
Efzofitimod for COVID-19: real-time analysis
Efzofitimod for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/lvl
Levilimab for COVID-19: real-time analysis
Levilimab for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/ad
Adintrevimab for COVID-19: real-time analysis of 3 studies
Adintrevimab for COVID-19: real-time analysis of 3 studies
covid 19 realtime analysis3 studies
https://c19early.org/ammeta.html
Amubarvimab/romlusevimab for COVID-19: real-time meta-analysis of 4 studies
4 amubarvimab COVID-19 controlled studies. 25% improvement, p = 0.51.
covid 19 realtime meta analysis4 studies
https://c19early.org/v
Sotrovimab for COVID-19: real-time analysis of 61 studies
Sotrovimab for COVID-19: real-time analysis of 61 studies
covid 19 realtime analysissotrovimab61studies
https://c19early.org/smeta.html
Remdesivir for COVID-19: real-time meta-analysis of 81 studies
81 remdesivir COVID-19 controlled studies. 4% increased risk, p = 0.36.
covid 19 realtime meta analysisremdesivir81studies
https://c19early.org/dfv
DFV890 for COVID-19: real-time analysis
DFV890 for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/sb
Sodium Bicarbonate for COVID-19: real-time analysis of 11 studies
Sodium Bicarbonate for COVID-19: real-time analysis of 11 studies
covid 19 realsodium bicarbonatetime analysis11studies
https://c19early.org/vv
Deuremidevir for COVID-19: real-time analysis of 8 studies
Deuremidevir for COVID-19: real-time analysis of 8 studies
covid 19 realtime analysis8 studies
https://c19early.org/ic1e
iC1e/K for COVID-19: real-time analysis
iC1e/K for COVID-19: real-time analysis
covid 19 realtime analysisk
https://c19early.org/il2
Interleukin-2 for COVID-19: real-time analysis of 2 studies
Interleukin-2 for COVID-19: real-time analysis of 2 studies
covid 19 realtime analysisinterleukin2studies
https://c19early.org/p
PVP-I for COVID-19: real-time analysis of 63 studies
PVP-I for COVID-19: real-time analysis of 63 studies
covid 19 realtime analysispvp63studies
https://c19early.org/n
Nitazoxanide for COVID-19: real-time analysis of 27 studies
Nitazoxanide for COVID-19: real-time analysis of 27 studies
covid 19 realtime analysis27studies
https://c19early.org/fm
Famotidine for COVID-19: real-time analysis of 37 studies
Famotidine for COVID-19: real-time analysis of 37 studies
covid 19 realtime analysisfamotidine37studies
https://c19early.org/ap
Andrographolide for COVID-19: real-time analysis of 43 studies
Andrographolide for COVID-19: real-time analysis of 43 studies
covid 19 realtime analysis43studies
https://c19early.org/cp
Convalescent Plasma for COVID-19: real-time analysis of 95 studies
Convalescent Plasma for COVID-19: real-time analysis of 95 studies
covid 19 realtime analysisconvalescentplasma95
https://c19early.org/clv
Clevudine for COVID-19: real-time analysis of 2 studies
Clevudine for COVID-19: real-time analysis of 2 studies
covid 19 realtime analysis2 studies
https://c19early.org/sp
Spironolactone for COVID-19: real-time analysis of 12 studies
Spironolactone for COVID-19: real-time analysis of 12 studies
covid 19 realtime analysis12 studiesspironolactone
https://c19early.org/b12
Vitamin B12 for COVID-19: real-time analysis of 26 studies
Vitamin B12 for COVID-19: real-time analysis of 26 studies
covid 19 realvitamin b12time analysis26studies
https://c19early.org/ppmeta.html
Propolis for COVID-19: real-time meta-analysis of 3 studies
3 propolis COVID-19 controlled studies. 41% improvement, p = 0.11.
covid 19 realtime meta analysis3 studiespropolis
https://c19early.org/ca
Cytokine Adsorption for COVID-19: real-time analysis of 2 studies
Cytokine Adsorption for COVID-19: real-time analysis of 2 studies
covid 19 realtime analysis2 studiescytokineadsorption
https://c19early.org/ppi
PPIs for COVID-19: real-time analysis of 44 studies
PPIs for COVID-19: real-time analysis of 44 studies
covid 19 realtime analysis44studies
https://c19early.org/t
Curcumin for COVID-19: real-time analysis of 110 studies
Curcumin for COVID-19: real-time analysis of 110 studies
covid 19 realtime analysiscurcumin110studies
https://c19early.org/slx
Siltuximab for COVID-19: real-time analysis of 3 studies
Siltuximab for COVID-19: real-time analysis of 3 studies
covid 19 realtime analysis3 studies
https://c19early.org/vd
Vadadustat for COVID-19: real-time analysis
Vadadustat for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/amc
Ammonium Chloride for COVID-19: real-time analysis of 2 studies
Ammonium Chloride for COVID-19: real-time analysis of 2 studies
covid 19 realtime analysis2 studiesammoniumchloride
https://c19early.org/il
Peginterferon Lambda for COVID-19: real-time analysis of 5 studies
Peginterferon Lambda for COVID-19: real-time analysis of 5 studies
covid 19 realtime analysis5 studieslambda
https://c19early.org/pt
Phthalocyanine for COVID-19: real-time analysis of 5 studies
Phthalocyanine for COVID-19: real-time analysis of 5 studies
covid 19 realtime analysis5 studies
https://c19early.org/gz
Glenzocimab for COVID-19: real-time analysis
Glenzocimab for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/lr
Leritrelvir for COVID-19: real-time analysis of 4 studies
Leritrelvir for COVID-19: real-time analysis of 4 studies
covid 19 realtime analysis4 studies
https://c19early.org/vvmeta.html
Deuremidevir for COVID-19: real-time meta-analysis of 2 studies
2 deuremidevir COVID-19 controlled studies. 11% improvement, p = 0.062.
covid 19 realtime meta analysis2 studies
https://c19early.org/bf
Bemnifosbuvir for COVID-19: real-time analysis of 5 studies
Bemnifosbuvir for COVID-19: real-time analysis of 5 studies
covid 19 realtime analysis5 studies
https://c19early.org/av
Avdoralimab for COVID-19: real-time analysis
Avdoralimab for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/nacl
NaCl for COVID-19: real-time analysis of 19 studies
NaCl for COVID-19: real-time analysis of 19 studies
covid 19 realtime analysisnaclstudies
https://c19early.org/ibmeta.html
Ibuprofen for COVID-19: real-time meta-analysis of 13 studies
13 ibuprofen COVID-19 controlled studies. 0% improvement, p = 0.96.
covid 19 realtime meta analysisibuprofen13studies
https://c19early.org/gmmeta.html
Sargramostim for COVID-19: real-time meta-analysis of 4 studies
4 sargramostim COVID-19 controlled studies. 13% increased risk, p = 0.64.
covid 19 realtime meta analysis4 studies
https://c19early.org/h1
Antihistamine H1RAs for COVID-19: real-time analysis of 28 studies
Antihistamine H1RAs for COVID-19: real-time analysis of 28 studies
covid 19 realtime analysisantihistamine28studies
https://c19early.org/tm
Trimodulin for COVID-19: real-time analysis
Trimodulin for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/pv
Pemivibart for COVID-19: real-time analysis of 12 studies
Pemivibart for COVID-19: real-time analysis of 12 studies
covid 19 realtime analysis12 studies
https://c19early.org/ast
Astegolimab for COVID-19: real-time analysis
Astegolimab for COVID-19: real-time analysis
covid 19 realtime analysis
https://c19early.org/udcameta.html
Ursodeoxycholic acid for COVID-19: real-time meta-analysis of 22 studies
22 ursodeoxycholic acid COVID-19 controlled studies. 18% improvement, p = 0.092.
covid 19 realtime meta analysisacid22studies
https://c19early.org/nf
Nafamostat for COVID-19: real-time analysis of 17 studies
Nafamostat for COVID-19: real-time analysis of 17 studies
covid 19 realtime analysis17 studies
https://c19early.org/naclmeta.html
NaCl reduces COVID-19 risk: real-time meta-analysis of 9 studies
9 NaCl COVID-19 controlled studies. 23% improvement, p = 0.0028.
reduces covid 19risk real timemeta analysisnaclstudies
https://c19early.org/ppimeta.html
Proton Pump Inhibitors increase COVID-19 risk: real-time meta-analysis of 40 studies
covid 19 riskreal time metaprotonpumpinhibitors